J. Philip Boudreaux, MD, FACS
Surgical Oncologist
Professor of Surgery
LSUHSC School of Medicine, New Orleans, Louisiana
Ochsner Health, Kenner, Louisiana
J. Philip Boudreaux, MD, FACS, is the featured guest for Luncheon with the Experts on February 18,2021. Dr. Boudreaux is Professor of Surgery at LSU Health Sciences Center School of Medicine with over 35 years as an experienced surgeon, transplant surgeon, critical care physician, and a member of the NOLA NETs (Neuroendocrine Tumors) multidisciplinary team. He also participates in Liver/Pancreas Transplant Services.
Dr. Boudreaux instituted the liver and pancreas transplant programs at LSU, performed the first pancreas transplant in Louisiana, and initiated the liver and kidney transplant programs at Children’s Hospital, New Orleans. His clinical interests include treatment of neuroendocrine tumors; hepatobiliary and pancreatic surgery; radiofrequency and NanoKnife ablation of solid tumors; and liver, pancreas, and kidney transplantation.
Dr. Boudreaux specializes in surgical oncology/cancer surgery; surgical treatment of complex neuroendocrine tumors such as carcinoid; pancreatic cancer, pancreatic surgery/Whipple procedure; complex liver and bile duct surgery; liver surgery for metastatic colon cancer; GIST (Gastrointestinal Stromal Tumors); stomach cancer/stomach surgery; and abdominal surgery. He also has expertise in NanoKnife and tumor ablation procedures and minimally invasive/laparoscopic surgery.
In addition to being Board Certified in Surgery, Dr. Boudreaux is Board Certified in Critical Care and holds a specialty certificate in Organ Transplant Immunology. He served as the Director of Liver/Pancreas/Kidney Transplant Services at LSU and Children’s Hospital pre-Katrina.
RESOURCES
To make an appointment with Dr. Boudreaux, click here: https://www.ochsner.org/services/neuroendocrine-tumor-program.
Selected Publications:
- A Neuroendocrine Tumor Specialty Center in New Orleans’ (NOLANETS) Response to Patient Care During the COVID?19 Pandemic
- Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?
- Prognostic Factors in Typical and Atypical Pulmonary Carcinoids
- Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
- Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma
- The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors
- Surgical Treatment of Advanced-Stage Carcinoid Tumors: Lessons Learned
Social Media:
NOLANETS on Facebook: https://www.facebook.com/nolanets
Ochsner Health on Facebook: https://www.facebook.com/OchsnerHealth
Ochsner Health on Twitter: https://twitter.com/OchsnerHealth
